[14C标记的7-[D(-)-α-(4-乙基-2,3-二氧代-1-哌嗪甲酰胺基)-α-(4-羟基苯基)乙酰胺基]-3-[(1-甲基-1H-四氮唑-5-基)硫甲基]-3-头孢烯-4-羧酸酯（14C-头孢哌酮）在大鼠和小鼠体内的吸收、分布及排泄研究] - Suppr | 超能文献

[Studies on the absorption distribution and excretion of 14C-labelled sodium 7-[D(-)-alpha-(4-ethyl-2,3-dioxo-1-piperazine-carboxamido)-alpha-(4-hydroxyphenyl l) acetamido]-3-[(1-methyl-1H-tetrazol-5-yl) thiomethyl]-3-cephem-4-carboxylate (14C-cefoperazone) in rats and mice].

作者信息

Saikawa I, Takai A, Nakashima Y, Ikegami T, Hayakawa H, Takagi T, Yamauchi H

出版信息

Jpn J Antibiot. 1980 Oct;33(10):1084-96.

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

[Studies on the absorption distribution and excretion of 14C-labelled sodium 7-[D(-)-alpha-(4-ethyl-2,3-dioxo-1-piperazine-carboxamido)-alpha-(4-hydroxyphenyl l) acetamido]-3-[(1-methyl-1H-tetrazol-5-yl) thiomethyl]-3-cephem-4-carboxylate (14C-cefoperazone) in rats and mice].[14C标记的7-[D(-)-α-(4-乙基-2,3-二氧代-1-哌嗪甲酰胺基)-α-(4-羟基苯基)乙酰胺基]-3-[(1-甲基-1H-四氮唑-5-基)硫甲基]-3-头孢烯-4-羧酸酯（14C-头孢哌酮）在大鼠和小鼠体内的吸收、分布及排泄研究]

Jpn J Antibiot. 1980 Oct;33(10):1084-96.

2

[The autoradiographic studies on the distribution of 14C-labelled sodium 7-[D(-)-alpha-(4-ethyl-2, 3-dioxo-1-piperazinecarboxamido)-alpha-(4-hydroxyphenyl)-acetamido]-3-[(1-methyl -1 H-tetrazol-5-yl) thiomethyl]-3-cephem-4-carboxylate (14C-cefoperazone) in rats and mice].[14C标记的7-[D(-)-α-(4-乙基-2,3-二氧代-1-哌嗪甲酰胺基)-α-(4-羟基苯基)乙酰胺基]-3-[(1-甲基-1H-四氮唑-5-基)硫甲基]-3-头孢烯-4-羧酸酯(14C-头孢哌酮)在大鼠和小鼠体内分布的放射自显影研究]

Jpn J Antibiot. 1980 Oct;33(10):1097-103.

3

[Studies on absorption, distribution and excretion of 14C labelled sodium 7 beta-[(2R, 3S)-2-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-3-hydroxybutanamido]-7-methoxy-3-[(1-methyl-1H-tetrazol-5-YL)thiomethyl]-3-cephem-4-carboxylate (14C-T-1982) in mice and rats].[14C标记的7β-[(2R,3S)-2-(4-乙基-2,3-二氧代-1-哌嗪甲酰胺基)-3-羟基丁酰胺基]-7-甲氧基-3-[(1-甲基-1H-四氮唑-5-基)硫甲基]-3-头孢烯-4-羧酸酯（14C-T-1982）在小鼠和大鼠体内的吸收、分布及排泄研究]

Jpn J Antibiot. 1982 Sep;35(9):2163-73.

4

[The whole body autoradiographic studies on the distribution of 14C-labelled sodium 7 beta-[(2R, 3S)-2-(4-ethyl-2, 3-dioxo-1-piperazine-carboxamido)-3-hydroxybutanamido]-7 alpha-methoxy-3-[(1-methyl-1H-tetrazol-5-yl)thiomethyl]-3-cephem-4-carboxylate (14C-T-1982) in mice].

Jpn J Antibiot. 1982 Sep;35(9):2159-62.

5

[Studies on beta-lactam antibiotics for medicinal purpose. XI. Studies on the metabolism of sodium 7-(D(-)-alpha-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-alpha-(4-hydroxyphenyl)acetamido)-3-((1-methyl-1H-tetrazole-5-yl)thiomethyl)-3-cephem-4-carboxylate (T-1551) (author's transl)].用于医学目的的β-内酰胺类抗生素研究。十一。7-（D（-）-α-（4-乙基-2,3-二氧代-1-哌嗪甲酰胺基）-α-（4-羟基苯基）乙酰胺基）-3-（（1-甲基-1H-四氮唑-5-基）硫甲基）-3-头孢烯-4-羧酸酯钠（T-1551）的代谢研究（作者译）

Yakugaku Zasshi. 1980 Jun;100(6):625-40.

6

[Studies on beta-lactam antibiotics for medicinal purpose. X. Stability and degradation pattern of sodium 7-[D(--)-alpha-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-alpha-(4-hydroxyphenyl)acetamido]-3-[(1-methyl-1H-tetrazol-5-yl)thiomethyl]-3-cephem-4-carboxylate (T-1551) in aqueous solution (author's transl)].药用β-内酰胺类抗生素的研究。X. 7-[D(-)-α-(4-乙基-2,3-二氧代-1-哌嗪甲酰胺基)-α-(4-羟基苯基)乙酰胺基]-3-[(1-甲基-1H-四氮唑-5-基)硫甲基]-3-头孢烯-4-羧酸酯钠（T-1551）在水溶液中的稳定性及降解模式（作者译）

Yakugaku Zasshi. 1979 Dec;99(12):1207-18. doi: 10.1248/yakushi1947.99.12_1207.

7

[Studies on absorption, distribution and excretion of 14C labeled pivaloyloxymethyl (+)-(6R,7R)- 7-[(Z)-2-(2-amino-4-thiazolyl)-2-methoxyiminoacetamido]- 3-[(5-methyl-2H-tetrazol-2-yl)methyl]-8-oxo-5-thia- 1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate (14C-T-2588) in rats and mice].

Jpn J Antibiot. 1986 Apr;39(4):979-90.

8

In vitro and in vivo antibacterial activity of T-1982, a new semisynthetic cephamycin antibiotic.新型半合成头孢霉素抗生素T-1982的体外和体内抗菌活性

Antimicrob Agents Chemother. 1982 Nov;22(5):728-34. doi: 10.1128/AAC.22.5.728.

9

The absorption, distribution and excretion of a new antithrombotic and vasodilating agent, cilostazol, in rat, rabbit, dog and man.

Arzneimittelforschung. 1985;35(7A):1124-32.

10

[Pharmacological study of beta-lactam antibiotics (15). Metabolism of sodium 7 beta-[(2R,3S)-2-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-3- hydroxybutanamido]-7 alpha-methoxy-3- [1-methyl-1H-tetrazol-5-yl) thiomethyl]-3-cephem-4-carboxylate (T-1982)].β-内酰胺类抗生素的药理学研究（15）。7β-[(2R,3S)-2-(4-乙基-2,3-二氧代-1-哌嗪甲酰胺基)-3-羟基丁酰胺基]-7α-甲氧基-3-[(1-甲基-1H-四氮唑-5-基)硫甲基]-3-头孢烯-4-羧酸钠（T-1982）的代谢

Yakugaku Zasshi. 1983 Apr;103(4):414-25.

引用本文的文献

1

Metabolic fate of [14C]SM-1652, a new antipseudomonal cephalosporin, after parenteral administration to rats.新型抗假单胞菌头孢菌素[14C]SM - 1652经大鼠非肠道给药后的代谢命运。

Antimicrob Agents Chemother. 1983 Jul;24(1):42-7. doi: 10.1128/AAC.24.1.42.

2

Disposition of moxalactam and N-methyltetrazolethiol in rats and monkeys.莫西拉坦和N-甲基四氮唑硫醇在大鼠和猴子体内的处置情况。

Antimicrob Agents Chemother. 1987 Aug;31(8):1169-76. doi: 10.1128/AAC.31.8.1169.